Stay informed with the latest litigation news. Explore now

IP Verse

Agios Pharmaceuticals patent opposition analysis

Latest patents of Agios Pharmaceuticals opposed by its competitors

Explore Agios Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3307271
Sep 13, 2023Methods Of Using Pyruvate Kinase Activators2
EP3713919
Aug 2, 2023Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide2

Top competitors of Agios Pharmaceuticals

Top competitors of Agios Pharmaceuticals based on patent oppositions.